Performance and Accuracy of an AI Enhanced Smart Watch Single lead ECG (PROCESS)

Overview

About this study

The purpose of this study is to show the artificial intelligence enhanced single-lead ECG Apple Watch has similar, robust performance comparable to an AI enhanced 12 lead ECG and AI enhanced single lead (LI) of a 12 lead ECG.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

Age ≥ 18 years and ≤ 89.
Able to give verbal consent.
Able to complete routine clinical 12 lead ECG tracing and single lead Apple Watch ECG tracing.

Exclusion Criteria:

Individuals < 18 and > 89 years of age.
Unable to given verbal consent.

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location	Status	Contact
Rochester, Minn. Mayo Clinic principal investigator Itzhak Zachi Attia, Ph.D.	Closed for enrollment	Contact information: Jennifer Dugan (507) 538-1125 Dugan.Jennifer@mayo.edu

Mayo Clinic Location

Status

Contact

Rochester, Minn.

Mayo Clinic principal investigator

Itzhak Zachi Attia, Ph.D.

Closed for enrollment

Contact information:

Jennifer Dugan

(507) 538-1125

Dugan.Jennifer@mayo.edu

More information

Publications

Publications are currently not available

Clinical Trials